Article Figures & Data
Tables
Cervical cancer screening for women with other HPV-related cancer Cotesting HPV and cervical cytology every 3 years; preferred for women age 30 and older Annual cervical cytology for 3 years, then every 3 years if negative; preferred for women under age 30, or if HPV testing is unavailable Anal cancer screening for women with other HPV-related high-grade anogenital dysplasia or cancer Annual symptom query, visual inspection, and digital anorectal examination Anal cytology can be considered, depending on the availability of high-resolution anoscopy (high-grade vulvar dysplasia and cancer are associated with higher risk than at other sites)
